Yu, Zhuoya
Ding, Mengfei
Cai, Yiqing
Lu, Tiange
Chen, Xiaomin
Zhou, Xiangxiang
Wang, Xin
Funding for this research was provided by:
National Natural Science Foundation of China (No.82170189, No.82270200)
China Postdoctoral Science Foundation (No. 2021T1404223)
Translational Research Grant of NCRCH (No.2020ZKMB01, No.2021WWB02)
Natural Science Foundation of Shandong Province (ZR2021YQ51)
Key Technology Research and Development Program of Shandong (No.2018CXGC1213)
Taishan Scholars Program of Shandong Province; Shandong Provincial Engineering Research Center of Lymphoma; Academic Promotion Programme of Shandong First Medical University (No. 2019QL018)
Article History
Received: 26 May 2023
Accepted: 13 September 2023
First Online: 3 October 2023
Declarations
:
: This study was approved by the Medical Ethical Committee of Shandong Provincial Hospital, and written informed consent in accordance with the Declaration of Helsinki was obtained from each patient and healthy donors. Informed consent was obtained from all patients and healthy donors in this study. All methods were carried out in accordance with declaration of Helsinki.
: Not applicable.
: The authors have no relevant conflicts.